Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

946 ARTÍCULOS , VIENDO DEL 316 AL 330

Identification and development of cGAS inhibitors and their uses to treat Alzheimer's disease

Alarcón-Espósito J, Nagiri RK, Gan L, Sinha SC.

Neurotherapeutics. 2025 Apr;22(3):e00536. doi: 10.1016/j.neurot.2025.e00536. Epub 2025 Jan 31.

Treatments of psychosomatic symptoms in Alzheimer's disease: a scoping review of the potential therapeutic effects of essential oils

Abdulghani MF, Barzegari R, Almagharbeh WT, Yazdani Z, Amandadi Ghotbabadi A, Seyed Bagheri SH, Alnaiem M, Dehghan M.

Psychogeriatrics. 2025 Mar;25(2):e70007. doi: 10.1111/psyg.70007.

Mitochondrial Alterations, Oxidative Stress, and Therapeutic Implications in Alzheimer's Disease: A Narrative Review

Spina E, Ferrari RR, Pellegrini E, Colombo M, Poloni TE, Guaita A, Davin A.

Cells. 2025 Feb 6;14(3):229. doi: 10.3390/cells14030229.

Recent Insights on the Role of Nuclear Receptors in Alzheimer's Disease: Mechanisms and Therapeutic Application

Shan X, Li D, Yin H, Tao W, Zhou L, Gao Y, Xing C, Zhang C.

Int J Mol Sci. 2025 Jan 30;26(3):1207. doi: 10.3390/ijms26031207.

Myeloperoxidase as a therapeutic target for oxidative damage in Alzheimer's disease

Rivera Antonio AM, Padilla Martínez II, Torres-Ramos MA, Rosales-Hernández MC.

J Enzyme Inhib Med Chem. 2025 Dec;40(1):2456282. doi: 10.1080/14756366.2025.2456282. Epub 2025 Feb 14.

A Review on Nanotechnology based In Situ Gelling System as a Reliable Weapon for Targeting Alzheimer's Disease via Intranasal Route

Deorankar P, Minglani VV, Prajapati BG, Patel MB.

CNS Neurol Disord Drug Targets. 2025;24(8):594-609. doi: 10.2174/0118715273335978250127070434.

Beneficial and Detrimental Effects of Uric Acid on Alzheimer's Disease

Tovchiga O, Inkielewicz-Stepniak I.

Curr Neuropharmacol. 2025;23(12):1493-1517. doi: 10.2174/011570159X349365250128072146.

Internet of Medical Things (IoMT) for Alzheimer Patient's Outcome

Lakshmipriya T, Gopinath SCB.

CNS Neurol Disord Drug Targets. 2025;24(7):491-493. doi: 10.2174/0118715273371149250218081425.

Immune Modulation in Alzheimer's Disease: From Pathogenesis to Immunotherapy

Balkhi S, Di Spirito A, Poggi A, Mortara L.

Cells. 2025 Feb 12;14(4):264. doi: 10.3390/cells14040264.

Phytomolecules as Alzheimer's therapeutics: A comprehensive review

Hussain MK, Ahmad M, Khatoon S, Khan MV, Azmi S, Arshad M, Ahamad S, Saquib M.

Eur J Med Chem. 2025 Apr 15;288:117401. doi: 10.1016/j.ejmech.2025.117401. Epub 2025 Feb 17.

The Potential Role of Phytochemicals in Alzheimer's Disease

Baranowska-Wójcik E, Gajowniczek-Ałasa D, Pawlikowska-Pawlęga B, Szwajgier D.

Nutrients. 2025 Feb 12;17(4):653. doi: 10.3390/nu17040653.

Innovations in noninvasive sensory stimulation treatments to combat Alzheimer's disease

Park JM, Tsai LH.

PLoS Biol. 2025 Feb 28;23(2):e3003046. doi: 10.1371/journal.pbio.3003046. eCollection 2025 Feb.

Antioxidants in anti-Alzheimer's disease drug discovery

Guo J, Zhu Y, Zhi J, Lou Q, Bai R, He Y.

Ageing Res Rev. 2025 May;107:102707. doi: 10.1016/j.arr.2025.102707. Epub 2025 Feb 26.

Role of RhoA-ROCK signaling inhibitor fasudil in Alzheimer disease

Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Mohammed SG.

Behav Brain Res. 2025 Apr 27;484:115524. doi: 10.1016/j.bbr.2025.115524. Epub 2025 Mar 3.

Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities

Wang L, Sooram B, Kumar R, Schedin-Weiss S, Tjernberg LO, Winblad B.

Alzheimers Dement. 2025 Mar;21(3):e70048. doi: 10.1002/alz.70048.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias